MedPath

A study of the effect of long-term anticholinergic administration -solifenacin succinate

Not Applicable
Conditions
overactive bladder
Registration Number
JPRN-UMIN000017260
Lead Sponsor
Hokkaido University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who has contraindication of solifenacin succinate 2)Patients with prostate cancer 3)Patients with dutrusor underactivity 4)Patients with history of urethral stricture 5)Patients with history of radiation therapy 6,7)Patients with bladder cancer, urinary tract stones, symptomatic urinary tract infection, recurrent urinary tract infection and interstitial cystitis. 8)Patients with using self catheterization 9)Patients with history of resistance to anti-holinergic agents 10)Any other patients who are regarded as unsuitable for this study by the investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We explore the factors that affect their usefulness in agent.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath